Piccolo Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Piccolo antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Piccolo |
| Clone | [6H9-B6] |
| Host Species | Mouse |
| Reactive Species | human, rat |
| Isotype | IgG2b kappa |
| Format | ATTO 680 conjugate |
| Size | 0.1 mg |
| Concentration | 1mg/mL |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Background Info: No cross-reactivity to Bassoon, band at ~550kDa correspondng to the molecular weight of Piccolo. Scientific Background: Piccolo, also referred to as Aczonin, is a large protein which consists of an N-terminal Zn2 finger, several piccolo-bassoon homology domains and C-terminal PDZ and C2 domains (1, 2). In general it is found together with bassoon, a related huge multi-domain protein of the CAZ (cytoskeletal matric assembled at active zones) (3). Piccolo is a scaffolding protein for proteins involved in endo- and exocytosis of synaptic vesicles. Piccolo has also been shown to interfere with clathrin medicated endocytosis by binding to the F-actin and dynamin binding protein Abp1 (2). |
| Immunogen | n/a |
| Other Names | [ACZ; Aczonin; PCLO; Pico; presynaptic cytomatrix protein], [Pclo; Pclo; Acz; Pico; Acz] |
| Gene, Accession # | Gene ID: 26875, NCBI: NP_001104266.1, UniProt: Q9QYX7 |
| Catalog # | MBS800013 |
| Price | $430 |
| Order / More Info | Piccolo Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Gerber S.H., Garcia J., Rizo J., Sudhof T.C. (2001) EMBO J. 20(7): 1605-1619. 2. Wang X., et al. (1999) J Cell Biol. 147(1): 151-162. 3. Dresbach T., et al. (2006) J Biol Chem. 281(9):6038- 6047. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies